chronic cisplatin induced nephropathy

Completed

• Conditions: cisplatin nephropathy; kidney injury due to cisplatin; 10029149

• Registration Number: NL-OMON43000
• Lead Sponsor: Radboud Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 500

Inclusion Criteria

age * 18 years old
last gift cisplatin more than 1 year ago
all doses of cisplatin
all original oncological diagnoses

Exclusion Criteria

none

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>number of patients with chronic cisplatin nephropathy (chronic kidney injury<br /><br>defined as a reduced GFR or biochemical signs of tubulopathy). </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Quality of life in patients with nephropathy versus no signs of nephropathy</p><br>